Pharmacy News
Risks for women smokers taking proton pump inhibitors
Women with a history of smoking may be at particular risk of hip fracture when using proton pump inhibitors (PPIs) long-term, according to a BMJ study. more →
Over 400 request prescription payment checks
A total of 434 pharmacy contractors requested a total of 5,623 prescription payment checks from the NHS Business Services Authority, due to possible errors caused by the computerised pricing system over the past three years. more →
Tighter controls needed over websites selling POMs to public
Tighter controls are needed over the online advertising of prescription drugs, researchers have concluded, after finding poor safety and side effects information on a number of websites selling statins to the public. more →
Different BP in arms may indicate risk of disease
Patients whose systolic blood pressure differs by 10mmHg or more between each arm are at increased risk of peripheral vascular disease and death, UK research suggests. more →
New Pharmacist Support trustees
Four trustees have joined the board of the charity Pharmacist Support. more →
Guidance issued to help hospitals engage with community sector
Hospital pharmacists wishing to refer patients for community pharmacy services can make use of a new referral form developed by NHS Employers, the PSNC and the RPS. more →
Resources developed to help support patients with persistent pain
New resources to help pharmacists manage patients with persistent pain have been developed by UCL School of Pharmacy and the United Kingdom Clinical Pharmacy Association. more →
Low-dose ulipristal controls bleeding in womb fibroids
Ulipristal 5mg can control bleeding in patients with uterine fibroids, according to two studies published online today in the New England Journal of Medicine. more →
Dual therapy with trastuzumab and lapatinib shows promise for patients with breast cancer
Dual treatment for HER2-positive breast cancer with lapatinib plus trastuzumab improves pathological complete response compared with monotherapy with either drug, according to data published online in The Lancet. more →
Calls to stop roll-out of NHS 111
Nine serious incidents have been reported with England’s pilot NHS 111 telephone service, it has emerged. more →
PRODUCT RECALL: Coloplast catheter valve MDA/2012/003)
The MHRA has issued a Medical Device Alert because Coloplast is recalling catheter valves due to a sterility issue. These devices are normally supplied sterile.
more →
Better audit trails needed to weed out counterfeits
Systems are needed to allow drugs to be tracked from the manufacturer all the way to the patient, to help in the battle against counterfeit medicines in the UK supply chain, according to the Royal Pharmaceutical Society. more →
Hip fracture risks for women smokers taking PPIs
Women with a history of smoking may be at particular risk of hip fracture when using proton pump inhibitors (PPIs) long-term, according to a BMJ study published online (31 January 2012). more →
Applications open for NPA bursary
Following the successful launch of the inaugural Health Education Foundation bursary in 2011, applications are now open for the 2012 bursary.
more →
iPhone app directs Kent teenagers to free condoms
Teenagers in Kent can download an iPhone application that tells them where they can access free condoms and local sexual health services. more →
Health Bill changes proposed to protect NHS from privatisation
Amendments to the controversial Health and Social Care Bill are due to be tabled by ministers this week, in a bid to prevent another revolt by cross-party peers against the proposed NHS reforms. more →
Scotland’s pharmacists join FAST stroke awareness drive
Community pharmacies in Scotland are joining the "FAST" campaign to help raise awareness of the signs and symptoms of stroke. more →
More genetic testing called for within NHS
Proposals for the widespread adoption of genomic technologies in the NHS were delivered to the Government last week by the Human Genomics Strategy Group. more →
MHRA denies failure to ensure medical device safety
The MHRA has hit out against Lancet editor Richard Horton, after he wrote two articles accusing the agency of failing to ensure the safety of medical devices. more →
Renewed calls made to suspend 100-hour pharmacy exemption
Renewed calls have been made to suspend 100-hour pharmacy applications until proposed changes to market entry arrangements in England have been finalised. more →
Government launches bowel cancer campaign
The Government has today launched a new campaign to help people spot the warning signs of bowel cancer. more →
Spending cuts putting NHS service redesign at risk
MPs are concerned that NHS trusts are "salami-slicing" budgets to meet Government spending targets, instead of focusing on the longer term and redesigning services to save money. more →
More multiples take over hospital outpatient dispensing
Large multiples are increasingly providing outpatient dispensary services to NHS hospitals, in what is becoming a growing market for private providers. more →
Cegedim Rx Announces New Medicines Service Functionality
Cegedim Rx has released PMR system improvements to support Nexphase customers in implementing the New Medicines Service. more →
Children’s medicines to come under spotlight in DH strategy
Issues surrounding prescribing for children will among the focus areas in the "Children’s and young people’s outcomes strategy", due to be unveiled later this year by the Department of Health. more →
Give colecalciferol products UK licence, urges Soni
Two colecalciferol products that are imported from Germany in substantial quantities for the treatment of vitamin D and calcium deficiencies should be given a UK licence, according to community pharmacist Ash Soni. more →
Synthetic process unveiled for producing artemisinin
The ever-growing demand for low-cost artemisinin could be met using a new synthetic process, according to an article published in the international edition of Angewandte Chemie. more →
Butterbur products toxic and should be withdrawn, says MHRA
Butterbur products are linked with liver toxicity and should be removed from the market, the MHRA has announced. more →
Public health framework sets out 66 indicators for success
The Department of Health has published 66 public health indicators that local authorities should use to assess improvements under the reformed public health service in England.
more →
Concerns raised over "substandard" PNAs governing market entry
Serious concerns about the quality of pharmaceutical needs assessments (PNAs) have been raised in response to the Department of Health’s proposals to change the market entry test for pharmacies in England. more →
PDA Union seeks recognition for Alliance Boots pharmacists
The PDA Union is seeking formal recognition as a trade union that can collectively represent members who work for Alliance Boots. more →
Company-led drug recall: Gaviscon Advance Aniseed Suspension
Gaviscon Advance Aniseed Suspension, 500ml bottles, PL 00063/0108. Batch number/ expiry: 1. 032076, Exp 01/11/2012 (1800 bottles affected), 2. 032077, Exp 01/11/2012 (2388 bottles affected). more →
Clearer audit trails would ease supply issues, say manufacturers
Drug manufacturers are calling for the legal separation of pharmacy wholesaling and dispensing functions, to help stabilise the UK medicine supply chain. more →
Pharmacist suspended from Register for one month after misusing Tesco Clubcard
Irregularities around the use of a Tesco Clubcard have led to a pharmacist being suspended from the Register for one month, by order of the fitness-to-practise committee of the General Pharmaceutical Council. more →
Three drugs rejected for NHS use when first-line colorectal cancer treatment fails
Cetuximab, bevacizumab and panitumumab should not be made available on the NHS in England and Wales for treating metastatic colorectal cancer that has progressed after first-line chemotherapy, according to final guidance. more →
Warning for pharmacist after inappropriate touching during examination in consultation room
A pharmacist who touched inappropriately a female patient during a consultation has received a warning as to his conduct from the fitness-to-practise committee of the General Pharmaceutical Council. more →
Warning for pharmacist who accepted police caution for cocaine possession
A pharmacist who accepted a police caution for being in possession of cocaine has been warned by the fitness-to-practise committee of the GPhC not to allow himself to be put in such a position again. more →
Anaphylaxis after vaccination of children very rare
Anaphylaxis remains an adverse event that occurs very rarely in children after immunisation, according to prospective surveillance carried out in the UK and Ireland. more →
Dementia falls risk linked with SSRI dose
Selective serotonin reuptake inhibitors are associated with a dose-dependent increase in falls risk among elderly people with dementia, a new study concludes. more →
Clamp down on free trade to protect supply chain, urges RPS
Free trade of medicines between EU states should be made illegal in order to protect the UK medicines supply chain, the Royal Pharmaceutical Society has proposed. more →
Fingolimod safety review launched over heart concerns
The European Medicines Agency has launched a safety review of multiple sclerosis drug fingolimod, following the unexplained death of a patient soon after starting treatment. more →
Talks ongoing over "illogical" NMS payment structure
Talks are still under way to try and resolve problems with the payment model designed for the new medicine service, the PSNC has confirmed. more →
SSRI use during pregnancy linked with neonatal pulmonary hypertension
Taking selective serotonin reuptake inhibitors during late pregnancy doubles the risk of persistent pulmonary hypertension in the newborn, researchers claim. more →
Data support efficacy of combined oral contraceptives for period pain relief
Combined oral contraceptives (COCs) appear to reduce the severity of dysmenorrhoea, according to a study published online in Human Reproduction. more →
GPhC wants greater flexibility
The General Pharmaceutical Council is calling for changes to the Pharmacy Order 2010, to give it more flexibility over setting the details of regulatory processes. more →
Formularies must include NICE drugs
Health secretary Andrew Lansley has reiterated the Government’s commitment to end England’s medicines postcode lottery. more →
Linagliptin, exenatide and erlotinib gain new SMC endorsements
Patients with type 2 diabetes in Scotland can benefit from the availability of two more drugs within the NHS, after the latest round of decision-making by the Scottish Medicines Consortium. more →
Data linking HRT and breast cancer questioned
Doubts have been cast on evidence linking hormone replacement therapy (HRT) with an increased risk of breast cancer, claim the authors of a new study. more →
Doubts cast over MHRA’s medicines law proposals
Proposed changes to medicines laws might not make the system "fit for purpose", the Royal Pharmaceutical Society has warned. more →
Plans to shelve wholesale dealer exemption meet opposition
Pharmacy organisations are against plans to remove an exemption to the Medicines Act which allows pharmacies to trade small quantities of medicines without the need for a wholesale dealer’s licence. more →
Lloydspharmacy in talks to launch adherence monitoring device Helius
A digital health product designed to monitor medicines adherence is expected to launch in September 2012. more →
Lansley to investigate alleged pharmacy discrimination against blind patient
Health secretary Andrew Lansley has vowed to look into an alleged incident in which a community pharmacy refused to issue a blind patient with a monitored dosage system unless the patient paid an additional fee. more →
More research needed to verify lapatinib’s value
Lapatinib is less effective than trastuzumab, and should not be used as a single anti-human epidermal growth factor receptor 2 (HER-2) treatment for the neoadjuvant management of breast cancer, suggests a new study. more →
Revalidation will look for good, not poor, practice
Revalidation will not involve regular, fixed-point tests aimed at rooting out poor performers, but will be designed to promote professional development and enhance performance, the GPhC has said. more →
CCGs must be allowed to innovate, say MPs
The new clinical commissioning groups (CCGs) must be held accountable for how they are performing, but they also need "some amount of discretion" to allow for innovation, say MPs. more →
Wholesalers call for third-party monitoring of branded drug supplies
The British Association of Pharmaceutical Wholesalers (BAPW) has called on pharmacy and manufacturers to support third-party monitoring and reporting of branded medicine supplies. more →
Seamless hospital-community transfer supported by new guidance
Providing a seamless care pathway for patients who transfer from hospital to the community is the topic of new guidance. more →
Saxagliptin among five drugs approved for NHS use in Wales
Saxagliptin is among five drugs to have been accepted for use within NHS Wales in the latest round of appraisals by the All Wales Medicines Strategy Group.
more →
Prove Tamiflu works, scientists challenge Roche
Scientists have challenged the makers of Tamiflu, Britain's first line of defence against emerging flu strains, to prove its effectiveness. more →
Thieves target pharmacy
Pharmacy suffered a "disproportionately high" number of thefts last year, according to a new survey. more →
GPhC brings first prosecution for practising while suspended
A man has been prosecuted after continuing to practise pharmacy while suspended from the Register, and will be brought back before the regulator’s fitness to practise committee. more →
Nilotinib recommended in new CML advice from NICE
Nilotinib has been recommended for the treatment of chronic myeloid leukaemia (CML) by the National Institute for Health and Clinical Excellence. more →
New antipsychotic for bipolar disorder
Asenapine, a new atypical antipsychotic for moderate to severe manic episodes associated with bipolar 1 disorder, will launch in the UK this week. more →
UK clinicians support low-dose bevacizumab for ovarian cancer
Addition of bevacizumab to standard therapy with carboplatin and paclitaxel improves progression-free survival for women with ovarian cancer who have high-risk disease. more →
Pharmacy and Public Health Forum outlines workstreams and group leads
Priorities that were outlined by the Pharmacy and Public Health Forum last October 2011 have been confirmed by the group, along with three others. more →
Guidance on antiepileptic use in HIV published
Evidence-based guidance to help prescribers choose antiepileptic drugs for patients with HIV/AIDS has been published by the American Academy of Neurology and the International League Against Epilepsy. more →
Dabigatran increases heart attack risk
Dabigatran increases the risk of heart attacks and acute coronary syndrome compared with standard anticoagulant therapy or placebo, a recent study suggests. more →
Pain knowledge should be improved for better care
Pharmacists need to develop a better understanding of basic differences between types of pain to determine right drug choice for their patients, according to Richard Langford, president of the British Pain Society. more →
Guideline on epilepsy management updated by NICE
Updates have been made to the guideline on the diagnosis and management of epilepsy from the National Institute for Health and Clinical Excellence. more →
Routine use of aspirin to protect heart not advisable
Routine use of aspirin for the primary prevention of cardiovascular events is not warranted, a new study has confirmed. more →
Assisted suicide proposals place pharmacists in charge of lethal drugs
Community pharmacists would have responsibility for storing lethal drugs used in assisted suicide if the law is changed to make the practice legal in the UK, it has been recommended. more →
Two-thirds of smokers try to quit in new year
Two-thirds of smokers in the UK, approximately six million people, will try and quit the habit in January, but half of them will fail within a week, new research suggests. more →
Pharmacists’ public health role should be incentivised, says forum
Community pharmacists could be paid more for their public health role, including supporting medicines management and offering healthy lifestyle advice, according to new recommendations from the NHS Future Forum. more →
Tact needed lest opportunistic interventions drive customers away
Opportunistic public health interventions are a good idea in principle, but must be carried out with care and tact so that patients are not deterred from visiting pharmacies, representatives of the profession have warned. more →
Prescription monitoring one of few methods shown to reduce drug misuse
Using monitoring systems to reduce inappropriate prescribing is one of few interventions that has been shown to reduce prescription drug misuse, according to an article in The Lancet. more →
Trusts advised to check employees are GPhC-registered
NHS trusts have been advised to check the registration status of all pharmacists and pharmacy technicians after more than 1,000 people were removed from the professional Register on 1 January 2012. more →
Public should be advised to have alcohol-free days
New drinking guidelines should be introduced in England advising people to have at least two alcohol-free days a week, MPs have recommended. more →
UK smoking and obesity rates among highest in developed world
The UK has the fifth highest proportion of adults who smoke or are obese in a comparison of 13 developed countries across the world. more →
Unite rejects "pernicious" NHS pension proposals
Unite, the parent trade union of the Guild of Healthcare Pharmacists, has officially rejected the latest Government proposals on NHS pension reforms. more →
Third of patients fail to take prescriptions to pharmacy
A third of patients fail to take prescriptions to their pharmacy following a GP visit, according to a survey published last week. more →
EMA to undertake four-year herbal medicines review
A four-year programme that is intended to ensure the safety of herbal medicines has been announced by the European Medicines Agency. more →
Epilepsy management in HIV subject of new guidance
Guidelines to help prescribers choose antiepileptic drugs for patients with HIV or AIDs have been published by the American Academy of Neurology and the International League Against Epilepsy. more →
Northern Ireland community pharmacists win funding cuts dispute
Community pharmacists in Northern Ireland have won a High Court victory over the Government in a dispute over plans to cut pharmacy funding. more →
Pharmacy manager struck off for theft of medicines
A pharmacist who stole medicines from his employer for his personal consumption has been removed from the Register by order of the Fitness-to-Practise Committee of the GPhC. more →
UCL School of Pharmacy formed
The School of Pharmacy, University of London, officially merged with University College London on 1 January 2012 to become the UCL School of Pharmacy. more →
Antidepressant prescribing up by 26 per cent
Levels of antidepressant and anti-anxiety drug prescribing in England have risen by 26 per cent since the beginning of the economic downturn, according to latest figures. more →
BHF launches hands-only CPR campaign
The British Heart Foundation (BHF) has launched a new campaign called 'Hands-only CPR' in a bid to encourage more people to give the life-saving treatment. more →
Extended nevirapine use in infants halves HIV transmission via breast milk
Nevirapine can safely be given to infants from birth up to six months of age to protect against mother-to-child transmission of HIV-1 via breastfeeding, according to a study published online in The Lancet. more →
"Ordinary" community pharmacist recognised in New Year honours list
Community pharmacist Lila Thakerar, who has run her own pharmacy in Harrow, Middlesex, for 19 years, has been awarded an MBE for services to the community in the New Year honours list for 2012. more →
BNF to star at the Olympics
The London Organising Committee of the Olympic and Paralympic Games (LOCOG) has teamed up with the British National Formulary in an agreement to produce the Medicines Formulary for the London 2012 event. more →
Patients free to choose GP of their choice, in DH pilot
Patients will soon be given the chance to register with a GP practice of their choice, in a pilot which, if successful, could be rolled out across England. more →
Erasure from Register after false accounting and theft
A pharmacist convicted of false accounting and theft has had his name removed from the Register by order of the Fitness to Practise committee of the General Pharmaceutical Council. more →
CD irregularities lead to suspension for 12 months
A number of Controlled Drugs irregularities have led to the suspension of a pharmacist from the Register by order of the Fitness to Practise Committee of the General Pharmaceutical Council. more →
One-month suspension after driving while disqualified
A one-month suspension from the Register has been handed by the Fitness-to-Practise Committee of the General Pharmaceutical Council to a pharmacist who drove while disqualified. more →
Sexual activity with 14-year-old girl sees pharmacist erased from Register
A pharmacist who had sexual activity with a 14-year-old girl has been erased from the Register by order of the Fitness-To-Practise committee of the General Pharmaceutical Council. more →
Care focus needs to shift from hospital to community
More NHS resources need to be shifted into community-based services, early intervention and self-care, according to Mike Farrar, chief executive of the NHS Confederation. more →
Patient online access to medical records by 2015 proposed
Patients should be given full access to their medical records within the next three years, the NHS Future Forum is to announce, according to a report in The Times. more →
Government to launch NHS whistleblowing helpline in new year
Plans to launch a free whistleblowing helpline on 1 January 2012 have been announced by health secretary Andrew Lansley. more →
Chlortalidone long-term benefits shown
Hypertension patients treated with chlortalidone-based therapy have a reduced rate of cardiovascular-related death more than 20 years later, according to a study published online in JAMA. more →
Decriminalisation amendment withdrawn — but Howe renews commitment to cause
A proposed amendment to the Health and Social Care Bill — which would have protected pharmacists against prosecution for genuine mistakes — has been withdrawn following parliamentary debate. more →
Floundering high streets need time limit for redevelopment ideas
Pharmacy Voice has joined in the debate about how to sustain England’s high streets by calling on the Government to introduce a time limit for implementing redevelopment ideas put forward by the local community. more →
Small study suggests lamotrigine-valproate duo best for epilepsy
A retrospective study of patients with epilepsy suggests a combination of lamotrigine and valproate is better at reducing seizures than 32 other frequently-used combinations of antiepileptic drugs (AEDs). more →
Share of £4.1bn announced for pharmaceutical services next year
NHS funding of £4.1bn for pharmaceutical and dental services and eye care and to support joint working between health and social care has been announced by health secretary Andrew Lansley. more →
Hand hygiene urged as winter vomiting bug spreads
Britons have been advised to practice hand hygiene measures after norovirus, known as the 'winter vomiting bug', forced a number of hospitals across the country to close wards to new admissions.
more →
Holidaymakers urged to take antimalarials
Britons who are heading to countries where malaria is prevalent over the festive period have been reminded to take anti-malaria tablets. more →
Fifth of TB patients don't complete treatment
One fifth of patients with tuberculosis are failing to complete their six-month course of antibiotics, according to latest annual figures from the Health Protection Agency. more →
Somatropin safe but indications and doses must be followed
Somatropin-containing medicines have been deemed safe to use in their approved indications and dosage, following a review by the European Medicines Agency’s Committee for Medicinal Products for Human Use. more →
UK scientists call for review of child penicillin dosing
Penicillin dosing guidelines for children need to be reviewed to reflect the increase in children's average weight over the past few decades, an article in the British Medical Journal suggests. more →
24,000 diabetes deaths are avoidable
Up to 24,000 people with diabetes die each year from causes that could have been avoided, experts say.
more →
Statins may aid flu treatment
People who are hospitalised with flu may benefit from taking cholesterol-lowering statin drugs, new research suggests. more →
HPV testing 'better than smear test alone' for preventing cervical cancer
A test that detects DNA from the human papillomavirus (HPV) is better than smear tests alone for preventing cervical cancer in over-30s, a study suggests. more →
Children’s medicines advice website launched
Pharmacists have been involved in creating a new website offering children’s medicines advice to parents. more →
Dexamethasone rejected by SMC despite approval by NICE
Dexamethasone has been rejected for use in Scotland for the treatment of patients with macular oedema. more →
Northern Ireland to consider bringing back prescription charges
Public consultation on the reintroduction of some prescription charges in Northern Ireland may begin early in the new year, according to the country’s health minister Edwin Poots. more →
NICE approves tocilizumab for juvenile arthritis
Tocilizumab has been recommended for use in the NHS in England and Wales for the treatment of active systemic juvenile idiopathic arthritis. more →
Pharmacy Voice calls for Sustainable Communities Act to be strengthened
Pharmacy Voice is calling on the Government to strengthen the Sustainable Communities Act (2007), as an official report warns that high streets have reached crisis point. more →
UK lung cancer care improving each year, audit shows
58.4 per cent of patients with lung cancer in England and Wales and 63.9 per cent in Scotland received an anti-cancer treatment in 2010, compared to 54 per cent and 64.1 per cent respectively in 2008, say new Government figures. more →
Side-effects lead one in three breast cancer patients to quit drugs
More than a third (36 per cent) of postmenopausal women with oestrogen-sensitive breast cancer stop taking their drugs early because of the side-effects, a study has found. more →
Fife pharmacist vies for Christmas number one slot
A village pharmacist from Fife is competing in the race for the UK singles chart Christmas number one after releasing a comedy charity song and music video. more →
British people more likely to protect their property than their health
UK Adults most at risk of influenza and pneumococcal disease are almost twice as likely to protect their home and belongings than their health, reveals a new survey. more →
Service providing free EHC ahead of festive season buckles under demand
A service providing free emergency hormonal contraception (EHC) to women in advance of the festive period has been overwhelmed with demand, and can no longer guarantee supply of the drug before Christmas. more →
Revised NHS pension proposals condemned by guild
Revised proposals for changing NHS pensions have been condemned by the Guild of Healthcare Pharmacists. more →
Brighton students take on "The Apprentice" style learning model
Pharmacy students at the University of Brighton are being set a series of tasks similar to those seen on BBC television show "The Apprentice", as part of a new way of learning. more →
Warning over exposing fentanyl patches to heat
Pharmacists supplying fentanyl patches should remind patients to avoid exposure of the patch to heat, which can increase the rate of release of the drug, the RPS has advised. more →
Research reveals burden created by RP Regulations
The wide-ranging burden created by the responsible pharmacist Regulations has been confirmed by research findings. more →
Health Research Authority launched as new clinical trials watchdog
Patients taking part in medical research have a new representative body in the form of the Health Research Authority, launched by the Government at the start of the month. more →
Landmark ruling improves patent landscape for multi-ingredient drugs
Pharmaceutical industry representatives have welcomed a European court ruling that is expected to offer greater patent protection for medicines. more →
Nine UK drugs under review over manufacturing concerns
Production for a number of drugs that are produced in the US-based manufacturing site Ben Venue are under review following a precautionary recall last month of the Ben Venue cancer drugs Busilvex (busulfan) and Velcade (bortezomib). more →
Pharmacovigilance law changes under consultation
A consultation on incorporating an EU Directive on pharmacovigilance into UK law has been launched by the Medicines and Healthcare products Regulatory Agency. more →
Major project launched to modernise prescribing data services
A major project to modernise information services relating to drug prescribing and dispensing volumes, trends and cost analyses is under way.
more →
Public not convinced of pharmacists’ abilities, warns Holden
Public recognition of what community pharmacists have to offer is still low, and does not reflect the reality, according to NPA chief executive Mike Holden. more →
Locum pharmacist suspended for false payment applications
A locum pharmacist has received a four-month suspension by the GPhC Fitness-to-Practise committee for making false applications for payment for services provided to Superdrug. more →
Pharmacist struck off after till theft
A pharmacist who accepted a police caution for theft has been erased from the Register by order of the Fitness-to-Practise Committee of the General Pharmaceutical Council. more →
Apixaban not better than enoxaparin for VTE prevention
An extended course of thromboprophylaxis with apixaban does not give better results than a shorter course with enoxaparin, according to a study published in the New England Journal of Medicine. more →
New antiretroviral launched in the UK
Rilpivirine, a new non-nucleoside reverse transcriptase inhibitor, has been launched in the UK for the management of HIV-1 infection in treatment-naive patients. more →
MURs for NSAIDs add value
Early data from the south east of England demonstrate the value of targeting medicines use reviews at patients taking non steroidal anti-inflammatory drugs. more →
AstraZeneca-academia deal paves way for new research model
AstraZeneca has signed what is being described as a landmark agreement with the Medical Research Council for sharing investigative drug compounds, a move that could become a new model for medicines research. more →
Chief pharmacists called on to manage homecare
NHS chief pharmacists should be responsible for managing all homecare medicine services within their trusts, according to a review published by the Department of Health last week. more →
Decriminalisation proposal could force Government to address the issue
Pharmacy organisations have welcomed a proposed amendment to the Health and Social Care Bill that aims to bring about the decriminalisation of dispensing errors. more →
Drug development and uptake set to speed up
Making sure NHS formularies reflect national recommendations on new drugs and giving drug companies access to anonymised patient data are part of a new Government strategy for driving life sciences in the UK. more →
Pfizer to cut pharmacy discount on its patented drugs
Pfizer is cutting the discount available to pharmacists on its patent-protected medicines by one per cent in an overhaul of its drugs discount scheme, the company has announced. more →
Public trust concerns over patient data sharing
Public trust in the life sciences sector could be damaged if Government proposals to share NHS patient data with researchers are not communicated with care, the RPS has warned. more →
Self-monitoring of oral anticoagulation therapy an option for some
Self-monitoring and self-management of oral anticoagulation therapy is a safe option for certain patients, according to a study published online in The Lancet. more →
Tenofovir accepted in Wales as hepatitis B treatment
Tenofovir (Viread) has been accepted for use within NHS Wales for the treatment of chronic hepatitis B in adults with decompensated liver disease. more →
CQC inspection duty failures “put patient care at risk”
Criticism has been levelled at the Care Quality Commission for apparently putting its registration responsibilities ahead of its duty to inspect hospital trusts and social care providers. more →
Bail denied to man charged with Nurofen contamination
Bail has been denied to the man charged with contaminating packs of Nurofen Plus earlier this year. more →
NHS pharmacist numbers rise in Scotland
The number of NHS pharmacist posts in Scotland increased by two per cent between September 2010 and September 2011, according to NHS Scotland workforce data published last week. more →
Evidence needed for APPG’s medicines supply inquiry
Pharmacists have been called on by the All-Party Pharmacy Group to submit written evidence to its inquiry into medicines shortages. more →
Smoking cessation services underutilised in Scotland
Smoking cessation services offered by community pharmacists in Scotland are not being put to full use, according to the results of an independent review commissioned by the Scottish Government. more →
Ranibizumab rejected by NICE for diabetic macular oedema
Ranibizumab should not be made available on the NHS in England and Wales for the treatment of diabetic macular oedema, according to final guidance from NICE. more →
Peter Noyce appointed to Modernising Pharmacy Careers board
Peter Noyce has been appointed co-chairman of the board of the Modernising Pharmacy Careers programme, a position he will share with England’s chief pharmaceutical officer Keith Ridge. more →
New hope for decriminalisation of dispensing errors
Decriminalisation of single dispensing errors has come a step closer with the tabling of an amendment to the Health and Social Care Bill, which is currently at the committee stage in the House of Lords. more →
Pharmacists want a boss with vision and direction
Vision and clear direction are considered the most important qualities of an employer by nearly a third of pharmacists, according to the results of a workforce survey. more →
Pharmacy can relieve NHS funding pressures
Making better use of pharmacy will be key to improving the NHS’s financial standing, chief executive of the PSNC Sue Sharpe has said. more →
Modafinil indication and dosage error in BNF 62
An error is included under the indications and dosage information for modafinil that are printed in the British National Formulary 62 (section 4.4, pp250–251). more →
Thumbs up for supply chain best practice guidance
Best practice guidance published earlier this year to deal with medicine supply problems, has been “very successful” in minimising the impact of shortages, according to health minister Simon Burns. more →
Free prescriptions loophole hits pharmacies on Welsh border
Loopholes in the regulation of cross-border prescriptions are causing pharmacies on the border with Wales to lose out, according to Joanne McMurray, member of the Shropshire local pharmaceutical committee. more →
NICE approves new drug to prevent blood clots after hip and knee surgery
A new drug called apixaban (brand name Eliquis) has been approved for use on the NHS to prevent life-threatening blood clots in patients undergoing hip and knee replacement surgery. more →
Number of 100-hour pharmacies opening each year has doubled
Pharmacy openings under the 100-hour exemption to control-of-entry rules have almost doubled in recent years, according to statistics released by the NHS Information Centre. more →
Cervarix dropped in favour of Gardasil for HPV vaccination programme
Gardasil will be used in the national human papilloma virus (HPV) vaccination programme from next year instead of Cervarix, the Department of Health has announced. more →
Paracetamol use during pregnancy linked with wheezing in children
Prenatal exposure to paracetamol could be associated with an increased risk of wheezing among young children, research suggests. more →
Plans on track to phase in paracetamol bottles displaying new children’s doses
All manufacturers of paediatric paracetamol suspensions in the UK have applied for approval for new packaging to reflect recent changes to dose ranges, the MHRA has confirmed. more →
Cegedim Rx Launches New Medicines Service Support
Following on from the launch of the New Medicines Service (NMS) in England, Cegedim Rx has taken a staged approach to supporting pharmacies, based on helping to identify patients that could be eligible for the service. more →
Massive call made to replace prescription pricing system
A prescription pricing system that uses data from the patient medication record system to produce an invoice for the NHS Business Services Authority has been proposed, in a bid to deliver more accurate pricing. more →
Time wasters
Two of the main time-wasting activities that community pharmacists are obliged to perform are chasing medicines when manufacturers and wholesalers are not prepared or are unable to supply, and chasing prescribers. more →
Latest speakers announced for self-care conference
McNeil Products' head of pharmacy, David Mitchell, and Professor David Taylor from the London School of Pharmacy are the latest speakers to sign up for Pharmacy Magazine's self care conference, to be held on February 9th. more →
Death risk from staggered paracetamol overdoses
People who regularly take slightly too much paracetamol over a period of time to relieve pain could be at a higher risk of dying than those who take a one-off overdose of the drug, a study has revealed. more →
New Medicine Service launch a resounding success
Early data on the New Medicine Service has been strong enough for PSNC to declare the launch a success. more →
Cancer survival has improved — but progress varies hugely between cancer types
People in the UK are now living six years longer, on average, after a cancer diagnosis than 40 years ago, according to latest research from the charity Macmillan Cancer Support. more →
Death more likely from paracetamol build-up than single overdose
People who cumulatively take slightly too much paracetamol over a week have a greater risk of death than people who take a single overdose, according to the authors of a study published today (23 November 2011). more →
Long-term statin benefits revealed in follow-up study
Benefits from statin therapy increase over time and persist for at least five years after treatment is stopped, according to a study published online today in The Lancet. more →
Darlington first PCT to complete summary care records roll-out
NHS Darlington has become the first primary care trust in England to have created summary care records for all patients who have agreed to be part of the shared NHS records initiative. more →
Enduring supply problems trigger full-scale inquiry by APPG
MPs and peers have announced they are holding an inquiry into the continuing problems around the NHS medicines supply chain. more →
Government signs WHO’s five-year antibiotic resistance action plan
The UK Government, along with other European Union members, has signed up to the World Health Organisation’s latest antibiotic resistance five-year action plan. more →
Kidney function tests needed to avoid fatal bleeding with dabigatran
All patients should have their kidney function tested before beginning treatment with the anticoagulant dabigatran, in order to reduce the risk of fatal bleeding, the European Medicines Agency has emphasised. more →
Patients need better antibiotics advice and support
Pharmacists and GPs should manage patient needs and expectations relating to antibiotic prescribing in an attempt to tackle increasing antimicrobial resistance, according to an expert group that convened recently at the Royal Society of Medicine in London. more →
Over half of people expect antibiotics for cold symptoms
More than half of people who visit a GP with cold symptoms expect to be given antibiotics, a survey has revealed, prompting the Health Protection Agency to publish its “top ten tips” for understanding antibiotics. more →
More data needed before flu vaccine advised for every child
More evidence is needed before the Joint Committee on Vaccination and Immunisation can recommend extending the seasonal influenza vaccination programme to include all healthy children under the age of 17 years. more →
Hospital pharmacists vote in favour of industrial action
Hospital pharmacists have voted in favour of industrial action over controversial NHS pension reform plans. more →
Grant wider health records access, urges future forum
Health records should be made accessible to all organisations involved in a patient’s care, according to interim public health recommendations from the NHS Future Forum. more →
Ex Numark boss joins CIG
Former Numark managing director David Wood has joined Communications International Group as Director of Clinical Services. more →
Denosumab shown to slow prostate cancer spread to bones
Denosumab slows the spread of prostate cancer to bones in men at risk of disease progression, according to a Lancet study. more →
BAPW proposes three-principle patient service obligation to protect supply chain
Pharmacy wholesalers are backing a campaign to establish a statutory obligation to protect the medicines supply chain and ensure patients receive their medicines within 24-hours of being dispensed. more →
Polypharmacy increases severity of erectile dysfunction, study suggests
The number of medicines taken by men is associated with increasingly severe erectile dysfunction, according to a study published online in the British Journal of Urology International. more →
Acute coronary syndrome patients benefit from rivaroxaban addition
Adding rivaroxaban to standard therapy for patients with an acute coronary syndrome (ACS) reduces their risk of cardiovascular death, myocardial infarction or stroke, according to a new study. more →
Oral contraceptive levels in environment linked with prostate cancer
Low levels of oral contraceptives in the environment could be associated with increased rates of prostate cancer, according to a study published in BMJ Open. more →
Patent law ruling simplifies application requirements
Pharmaceutical scientists now have a much clearer idea about the level of detail they need to include when they are applying for a patent, following a ruling by the Supreme Court this month. more →
Complaint over Boots homoeopathy adverts upheld by MHRA
A complaint against Boots over advertisements for homoeopathic products that appeared in some of its stores has been upheld following an MHRA investigation. more →
Petition drums up parliamentary support for antibiotics development
A petition calling for Government to support the discovery and development of new antibiotics has resulted in the tabling of an Early Day Motion on the issue. more →
Alphega Pharmacy UK to partner with Sigma Pharmaceuticals
Alphega Pharmacy, the pan-European membership organisation for independent pharmacies, has announced a new partnership with pharmaceutical wholesaler and distributor Sigma Pharmaceuticals. more →
Sainsbury’s takes over outpatient dispensing at South Tees
Sainsbury’s and Healthcare at Home will provide outpatient dispensing services at South Tees Hospital NHS Foundation Trust from early next year, it was confirmed last week. more →
Intensive insulin therapy could halve kidney disease risk
Early intensive therapy for type I diabetes can lower the risk of kidney disease, according to a study published online in the New England Journal of Medicine. more →
FIP report underscores pharmacists’ role in diabetes care
A report highlighting pharmacists’ contribution to diabetes care has been published by the International Pharmaceutical Federation. more →
Lower BMI limits for South Asian people advised by researchers
The threshold for being obese should be lowered for people of South Asian origin, researchers from the University of Leicester have said. more →
DH publishes influenza pandemic strategy
An updated strategy on how the UK should respond to an influenza pandemic has been published by the Department of Health. more →
Citalopram maximum daily dose lowered to 40mg
The maximum dose of citalopram has been lowered to 40mg because of new data linking it with a dose-dependent increase in QT interval. more →
Colorectal cancer guidance published by NICE
Colorectal cancer guidance covering the diagnosis and management of the condition has been published by the National Institute for Health and Clinical Excellence. more →
Guide launched to make prisons safer
Prison pharmacists can reduce risks involved with medicines prescribing in prisons and ensure the cost-effective use of drugs, according to guidance for prescribing in prisons published this week. more →
LLoydspharmacy pharmacists facing 'intolerable' medicines supply issues
Eight in 10 pharmacists at Lloydspharmacy are not able to dispense prescription items due to supply issues, according to a survey by the multiple. more →
Pharmacist convicted for drug theft and fraud is erased from Register
A pharmacist convicted of theft, fraud and making a false instrument has had his name removed from the Register by order of the Fitness to Practise Committee of the GPhC. more →
Caution for false accounting leads to 12-month suspension from Register
False accounting and acceptance of a police caution have led to a pharmacist being suspended from the Register for 12 months by order of the Fitness to Practise Committee of the GPhC.
more →
Nationwide video campaign asks public to 'Choose Well'
"Choose Well", a nationwide video campaign, is supporting Ask Your Pharmacist week (7–11 November 2011) by highlighting the treatments and advice available in community pharmacies. more →
Boost for pharmacy prescribers
The All-Wales Medicines Strategy Group has pledged to commission three studies into the positive impact of non-medical prescribing on patient care.